Medical University Of Vienna — Sponsor Intelligence | 84 EU Trials

Filter these 84 trials by condition, phase, country and more.

Open in Search →

84 Registered trials

56 Recruiting

16 Completed trials

12 Countries active

119 Unique IMPs

100% Results reported

Phase II

Phase IV

Phase I (Other)

Phase III: 4 Phase II: 29 Phase I/II: 2 Phase III/IV: 3 Phase IV: 22 Phase I: 5 Phase I (Other): 19

100%

16 of 16 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Antidepressant therapy 2 Anhedonia 2 Ejection fraction normal 1 Polymyalgia rheumatica 1 Sinus rhythm 1 Acute graft versus host disease in skin 1 Aortic disorder 1 Dermatomyositis 1 Negative symptoms in schizophrenia 1 Schizoaffective disorder depressive type 1 Antisynthetase syndrome 1 Immune-mediated myositis 1

Top IMPs

DUPILUMAB 4 CEFAZOLIN 3 ESKETAMINE HYDROCHLORIDE 3 LANDIOLOL HYDROCHLORIDE 3 PROPOFOL 3 SODIUM CHLORIDE 3 AMPICILLIN SODIUM 2 BEVACIZUMAB 2 CEFUROXIME SODIUM 2 GENTAMICIN 2 GOZETOTIDE 2 HEPARIN SODIUM 2

All trials

84 total

Psilocybin's effects on anhedonia Not authorised

2023-509009-59-00 Phase I (Other) 1 country
A Clinical Trial of OM336 to Help Immunized Patients Become Eligible for Kidney Transplantation Not authorised

2025-523222-40-00 Phase II 1 country OM336
Unraveling the aesthetic mind in anhedonia, insights from pharmacological imaging of the human brain: A single-blind, randomized, placebo-co… Pending

2024-517252-35-00 Phase I (Other) 1 country
SGLT2 lnhibition in Hemodialysis (DAPA-HD) Pending

2024-518591-31-00 Phase II 1 country DAPAGLIFLOZIN
Long-term effect of Dupilumab on acetylsalicylic acid (ASA) intolerance and its mechanisms in patients with non-steroidal anti-inflammatory … Pending

2024-520082-31-01 Phase IV 1 country DUPILUMAB
Genitourinary Syndrome and Female Sexual Dysfunction: Effect of topical glyceryl trinitrate on female genital function in the peri- and post… Pending

2025-520741-68-00 Phase I (Other) 1 country
Platelet function testing in outpatients after heart transplantation on aspirin therapy Pending

2025-521699-71-01 Phase IV 1 country ACETYLSALICYLIC ACID
The effect of early Landiolol in patients with ST-elevation acute coronary syndrome undergoing primary percutaneous coronary intervention – … Pending

2025-523676-23-00 Phase IV 1 country LANDIOLOL HYDROCHLORIDE
DIRECTION Study Pending

2025-524495-39-00 Phase IV 1 country DUPILUMAB; TEZEPELUMAB
Pharmacokinetics of Aztreonam-Avibactam in Critically Ill Patients with Sepsis Receiving ECMO Support: A Prospective PK Study Pending

2025-524614-28-00 Phase I (Other) 1 country
SISTAR: Stratifying Immunosuppression to Allogenic Risk. A randomized, open label, assessor blinded, controlled, non-inferiority, safety stu… Pending

2025-525091-29-00 Phase II 1 country BELATACEPT
LAFOV-Lung PET Pending

2026-525834-45-00 Phase I 1 country
Venetoclax as treatment of acute graft-versus-host disease Recruiting

2025-520545-74-00 Phase II 1 country VENETOCLAX
ISA-PET Recruiting

2024-515704-39-00 Phase I (Other) 1 country
Phase II Study of daTopotamab-derUXtecan (Dato-DXd; DS-1026a) in triple-negative brEast cancer patients with newly Diagnosed or prOgressing … Recruiting

2024-518819-19-00 Phase II 2 countries DATOPOTAMAB DERUXTECAN
Selective serotonin reuptake inhibition in patients with advanced gastroesophageal cancer receiving immunochemotherapy: a prospective phase … Recruiting

2024-518631-11-00 Phase II 1 country SERTRALINE
H1-antihistaminE treatment in combiNation with immunotHerapy in pAtieNts with advanced non small cell lung canCEr: A single- center phase -E… Recruiting

2024-518633-28-00 Phase II 1 country FEXOFENADINE HYDROCHLORIDE
The effect of anifrolumab on cutaneous lupus erythematosus characterized by the change of the inflammatory infiltrate analyzed by immunohist… Recruiting

2025-523133-26-00 Phase IV 1 country ANIFROLUMAB
Psilocybin's effects on anhedonia Recruiting

2024-519265-22-00 Phase I (Other) 1 country
TezeBarrier Study Recruiting

2024-517538-16-00 Phase IV 1 country
Plasma and intraperitoneal pharmacokinetics of cefiderocol in peritoneal dialysis patients Recruiting

2024-518220-72-00 Phase I (Other) 1 country
A phase II study assessing safety and efficacy of REPotrectinib in ROS1-positive non-small cell lung cancer patients with active brain mEtas… Recruiting

2023-508112-35-00 Phase II 3 countries REPOTRECTINIB
EXPOSURE Study Recruiting

2024-513353-73-00 Phase II 1 country EDOXABAN
TECA study Recruiting

2024-513351-33-00 Phase II 1 country TELMISARTAN

Showing 1–24 of 84 trials

← All sponsors A–Z